
    
      The investigators will collect a blood sample for the study when the participant has other
      blood tests drawn for their cancer treatment. The investigators will take one sample to check
      prostate specific antigen (PSA) levels and another blood sample for CTC analysis. The
      investigators will be drawing blood at the following time points: Screening; One day after
      surgery; 7-14 days after surgery; 3-6 months after surgery; at PSA recurrence or at two
      years.
    
  